These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 36018472)
1. Best Practices for Designing Informative Trials Including Women. Nicolas J; Edens M; Vogel B; Mehran R Curr Atheroscler Rep; 2022 Nov; 24(11):885-888. PubMed ID: 36018472 [TBL] [Abstract][Full Text] [Related]
2. Strategies for Improving Enrollment of Diverse Populations with a Focus on Lipid-Lowering Clinical Trials. Ogungbe O; Grant JK; Ayoola AS; Bansah E; Miller HN; Plante TB; Sheikhattari P; Commodore-Mensah Y; Turkson-Ocran RN; Juraschek SP; Martin SS; Lin M; Himmelfarb CR; Michos ED Curr Cardiol Rep; 2023 Oct; 25(10):1189-1210. PubMed ID: 37787858 [TBL] [Abstract][Full Text] [Related]
3. The impact of cardiovascular disease prevalence on women's enrollment in landmark randomized cardiovascular trials: a systematic review. Tsang W; Alter DA; Wijeysundera HC; Zhang T; Ko DT J Gen Intern Med; 2012 Jan; 27(1):93-8. PubMed ID: 21713543 [TBL] [Abstract][Full Text] [Related]
4. Improving diversity in cardiac surgery clinical trials with ROMA:Women as an exemplar. Masterson Creber R; Eslami S; Gaudino M Curr Opin Cardiol; 2024 Sep; 39(5):426-430. PubMed ID: 38935044 [TBL] [Abstract][Full Text] [Related]
5. Women's Participation in Cardiovascular Clinical Trials From 2010 to 2017. Jin X; Chandramouli C; Allocco B; Gong E; Lam CSP; Yan LL Circulation; 2020 Feb; 141(7):540-548. PubMed ID: 32065763 [TBL] [Abstract][Full Text] [Related]
6. Increasing Participation of Women in Cardiovascular Trials: JACC Council Perspectives. Cho L; Vest AR; O'Donoghue ML; Ogunniyi MO; Sarma AA; Denby KJ; Lau ES; Poole JE; Lindley KJ; Mehran R; J Am Coll Cardiol; 2021 Aug; 78(7):737-751. PubMed ID: 34384555 [TBL] [Abstract][Full Text] [Related]
7. Participation in clinical trials among women living with HIV in Canada. Canadian Women's HIV Study Group. Hankins C; Lapointe N; Walmsley S CMAJ; 1998 Dec; 159(11):1359-65. PubMed ID: 9861204 [TBL] [Abstract][Full Text] [Related]
8. Women in clinical trials: a review of policy development and health equity in the Canadian context. Yakerson A Int J Equity Health; 2019 Apr; 18(1):56. PubMed ID: 30987636 [TBL] [Abstract][Full Text] [Related]
9. Follow YOUR Heart: development of an evidence-based campaign empowering older women with HIV to participate in a large-scale cardiovascular disease prevention trial. Zanni MV; Fitch K; Rivard C; Sanchez L; Douglas PS; Grinspoon S; Smeaton L; Currier JS; Looby SE HIV Clin Trials; 2017 Mar; 18(2):83-91. PubMed ID: 28277924 [TBL] [Abstract][Full Text] [Related]
10. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
11. The role of the NIH's Office of Research on Women's Health. Pinn VW Acad Med; 1994 Sep; 69(9):698-702. PubMed ID: 8074758 [TBL] [Abstract][Full Text] [Related]
12. Involving minority and underrepresented women in clinical trials: the National Centers of Excellence in Women's Health. Killien M; Bigby JA; Champion V; Fernandez-Repollet E; Jackson RD; Kagawa-Singer M; Kidd K; Naughton MJ; Prout M J Womens Health Gend Based Med; 2000 Dec; 9(10):1061-70. PubMed ID: 11153102 [TBL] [Abstract][Full Text] [Related]
13. Overcoming Barriers to Parkinson Disease Trial Participation: Increasing Diversity and Novel Designs for Recruitment and Retention. Vaswani PA; Tropea TF; Dahodwala N Neurotherapeutics; 2020 Oct; 17(4):1724-1735. PubMed ID: 33150545 [TBL] [Abstract][Full Text] [Related]
14. Improving representativeness in trials: a call to action from the Global Cardiovascular Clinical Trialists Forum. Filbey L; Zhu JW; D'Angelo F; Thabane L; Khan MS; Lewis E; Patel MR; Powell-Wiley T; Miranda JJ; Zuhlke L; Butler J; Zannad F; Van Spall HGC Eur Heart J; 2023 Mar; 44(11):921-930. PubMed ID: 36702610 [TBL] [Abstract][Full Text] [Related]
15. Representation of women in randomized clinical trials of cardiovascular disease prevention. Melloni C; Berger JS; Wang TY; Gunes F; Stebbins A; Pieper KS; Dolor RJ; Douglas PS; Mark DB; Newby LK Circ Cardiovasc Qual Outcomes; 2010 Mar; 3(2):135-42. PubMed ID: 20160159 [TBL] [Abstract][Full Text] [Related]
16. Participation of women in clinical trials of drug therapies: a context for the controversies. Prout MN; Fish SS Medscape Womens Health; 2001 Oct; 6(5):1. PubMed ID: 11698923 [TBL] [Abstract][Full Text] [Related]
17. Participation of Women in Clinical Trials Supporting FDA Approval of Cardiovascular Drugs. Scott PE; Unger EF; Jenkins MR; Southworth MR; McDowell TY; Geller RJ; Elahi M; Temple RJ; Woodcock J J Am Coll Cardiol; 2018 May; 71(18):1960-1969. PubMed ID: 29724348 [TBL] [Abstract][Full Text] [Related]
18. Equitable Representation of Latinos in Clinical Research Is Needed to Achieve Health Equity in Cancer Care. Ramirez AG; Chalela P JCO Oncol Pract; 2022 May; 18(5):e797-e804. PubMed ID: 35544655 [TBL] [Abstract][Full Text] [Related]
19. Barriers to Participation in Therapeutic Clinical Trials as Perceived by Community Oncologists. Wong AR; Sun V; George K; Liu J; Padam S; Chen BA; George T; Amini A; Li D; Sedrak MS JCO Oncol Pract; 2020 Sep; 16(9):e849-e858. PubMed ID: 32240068 [TBL] [Abstract][Full Text] [Related]
20. Sex Disparities in Cardiovascular Device Evaluations: Strategies for Recruitment and Retention of Female Patients in Clinical Device Trials. Ghare MI; Chandrasekhar J; Mehran R; Ng V; Grines C; Lansky A JACC Cardiovasc Interv; 2019 Feb; 12(3):301-308. PubMed ID: 30732736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]